| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.RCL.2004.09.005 |
| P698 | PubMed publication ID | 15693654 |
| P2093 | author name string | David A Mankoff | |
| Anthony F Shields | |||
| Kenneth A Krohn | |||
| P433 | issue | 1 | |
| P304 | page(s) | 153-167 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Radiologic Clinics of North America | Q15755454 |
| P1476 | title | PET imaging of cellular proliferation | |
| P478 | volume | 43 |
| Q37929599 | A systemic review of PET and biology in lung cancer |
| Q27000462 | Advances in molecular imaging for breast cancer detection and characterization |
| Q36341240 | Advances in positron emission tomographic imaging of lung cancer |
| Q35082412 | Applications of Molecular Imaging |
| Q33943514 | Broadening the scope of image-guided radiotherapy (IGRT). |
| Q36561609 | Cancer biomarkers: a systems approach |
| Q39213065 | Characterization and cellular interaction of fluorescent-labeled PHEMA nanoparticles |
| Q36639914 | Current and future use of positron emission tomography (PET) in breast cancer |
| Q37817035 | Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment |
| Q38217835 | Current molecular imaging positron emitting radiotracers in oncology |
| Q38090509 | Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response |
| Q33924541 | Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas |
| Q35565997 | Effectiveness of PET/CT with (18)F-fluorothymidine in the staging of patients with squamous cell head and neck carcinomas before radiotherapy |
| Q37227814 | FLT-PET imaging of radiation responses in murine tumors |
| Q34692196 | Fetal dose estimates for (18)F-fluoro-L-thymidine using a pregnant monkey model |
| Q36501278 | Hypoxia imaging-directed radiation treatment planning |
| Q28066696 | Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography |
| Q39606309 | Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imaging |
| Q37608319 | Imaging the immune response to monitor tumor immunotherapy. |
| Q37782269 | Imaging the life and death of tumors in living subjects: Preclinical PET imaging of proliferation and apoptosis |
| Q40261034 | Instant gratification must wait |
| Q30659261 | Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of Cancer |
| Q34786518 | Metabolic positron emission tomography imaging in cancer detection and therapy response |
| Q51147434 | Molecular Probes for Imaging the Sigma-2 Receptor: In Vitro and In Vivo Imaging Studies. |
| Q37019264 | Molecular imaging as a tool for translating breast cancer science |
| Q22122025 | Molecular imaging in drug development |
| Q39890316 | Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose |
| Q36129937 | Molecular imaging of prostate cancer: PET radiotracers |
| Q35793157 | Molecular imaging research in the outcomes era: measuring outcomes for individualized cancer therapy |
| Q38838285 | Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers |
| Q36345342 | Molecular imaging: what can be used today. |
| Q39192946 | Monitoring tumor proliferative response to radiotherapy using (18)F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67. |
| Q34503914 | Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer |
| Q37084904 | Non-invasive imaging of adaptive immunity using positron emission tomography |
| Q38670632 | Novel positron emission tomography radiotracers in brain tumor imaging |
| Q37200462 | Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia |
| Q37401153 | PET Radiotracers for Imaging the Proliferative Status of Solid Tumors |
| Q37374442 | PET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development |
| Q37390670 | PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer |
| Q38221774 | PET/CT imaging in cancer: current applications and future directions |
| Q36308766 | PET/CT in prostate cancer: non-choline radiopharmaceuticals |
| Q48144049 | Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response |
| Q35626845 | Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate |
| Q55951082 | Positronen-Emissions-Tomographie |
| Q36680090 | Practices and pitfalls of mouse cancer models in drug discovery. |
| Q34175770 | Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials |
| Q36528175 | Targeted molecular imaging in oncology: focus on radiation therapy |
| Q37848518 | The evolution of imaging in cancer: current state and future challenges |
| Q38235857 | The evolving role of neurological imaging in neuro-oncology. |
| Q34907192 | The role of DNA synthesis imaging in cancer in the era of targeted therapeutics |
| Q38441129 | Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer |
| Q37306005 | Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2. |
| Q35173093 | Translational molecular imaging for cancer |
| Q33231305 | Use of 3'-deoxy-3'-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors |
| Q35031049 | Utility of [18 F]FLT-PET to assess treatment response in trastuzumab-resistant and trastuzumab-sensitive HER2-overexpressing human breast cancer xenografts |
| Q37237613 | Visualizing cancer and immune cell function with metabolic positron emission tomography |
Search more.